Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas

E Eva Dombi A Andrea M. Gross (Eva Dombi, MD, Andrea M. Gross, MD, and Brigitte C. Widemann, MD, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Brian D. Weiss, MD, Pediatric Hematology-Oncology, Riley Hospital for Children, Indiana University, Indianapolis, IN; Scott R. Plotkin, MD, PhD, Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, MA; and Shivani Ahlawat, MD, Russell H. Morgan Department of Radiology & Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD) B Brigitte C. Widemann B Brian D. Weiss (Department of Pediatrics, Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH) S Scott R. Plotkin S Shivani Ahlawat

Article Details

Volume / Issue Vol. 43, Issue 15
Published May 20, 2025
Pages 1843-1844
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (6)

E

Eva Dombi

A

Andrea M. Gross

Eva Dombi, MD, Andrea M. Gross, MD, and Brigitte C. Widemann, MD, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Brian D. Weiss, MD, Pediatric Hematology-Oncology, Riley Hospital for Children, Indiana University, Indianapolis, IN; Scott R. Plotkin, MD, PhD, Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, MA; and Shivani Ahlawat, MD, Russell H. Morgan Department of Radiology & Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD

B

Brigitte C. Widemann

B

Brian D. Weiss

Department of Pediatrics, Division of Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

S

Scott R. Plotkin

S

Shivani Ahlawat